Original Research

Published on 03 May 2024

Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data

in Thoracic Oncology

Guotian Pei
Kunkun Sun
Yingshun Yang
Shuai Wang
Mingwei Li
Xiaoxue Ma
Huina Wang
Libin Chen
Jiayue Qin
Shanbo Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1388575

1,012 views
1 citation

Original Research

Published on 30 Apr 2024

Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan

in Thoracic Oncology

Taher Abu Hejleh
Karim AlSawalha
Sufian Abdel Hafiz
Tamer Al-Batsh
Roaa Abu Hejleh
Sameer Yaser
Husam Abu Jazar
Jamal Khader
Anoud Alnsour
Issa Mohamad

Frontiers in Oncology

doi 10.3389/fonc.2024.1369126

1,555 views

Systematic Review

Published on 24 Apr 2024

First-line immunotherapy efficacy in advanced squamous non-small cell lung cancer with PD-L1 expression ≥50%: a network meta-analysis of randomized controlled trials

in Thoracic Oncology

Wei Chen
Hangmei Liu
Yiwen Li
Wenxin Xue
Shuo Fan
Jingbo Sun
Shui Liu
Yang Liu
Lili Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1365255

1,705 views

Case Report

Published on 23 Apr 2024

ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report

in Thoracic Oncology

Rui Chen
Yan Jian
Yuzhen Liu
Junping Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1395654

1,477 views

Case Report

Published on 23 Apr 2024

Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression

in Thoracic Oncology

Huimin Zhang
Xiaofeng Cong
Jiaxin Yin
Chen Chen
Ziling Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1387388

1,299 views

Case Report

Published on 22 Apr 2024

Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review

in Thoracic Oncology

Wenjuan Zhong
Longqiu Wu
Lixing Huang
Jianfeng Wang
Huaqiu Shi
Shugui Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1377451

2,084 views
1 citation

Original Research

Published on 22 Apr 2024

TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations

in Thoracic Oncology

Armin Frille
Myriam Boeschen
Hubert Wirtz
Mathias Stiller
Hendrik Bläker
Maximilian von Laffert

Frontiers in Oncology

doi 10.3389/fonc.2024.1357583

966 views
1 citation

Case Report

Published on 19 Apr 2024

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

in Thoracic Oncology

Siyuan Huang
Linlin Li
Ningning Yan
Huixian Zhang
Qianqian Guo
Sanxing Guo
Di Geng
Xincheng Liu
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1331387

1,089 views
1 citation

Editorial

Published on 19 Apr 2024

Editorial: Updates on combination therapy for lung cancer volume II

in Thoracic Oncology

Alberto Pavan
Liyun Shi
Muhammad Abbas

Frontiers in Oncology

doi 10.3389/fonc.2024.1393278

574 views

Case Report

Published on 18 Apr 2024

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

in Thoracic Oncology

Dan Li
Yue Zhu
Jincheng Song
Dafu Yang
Saiqiong Cui
Xin Liu
Le Wang
Jiangyan Zhang
Evenki Pan
Zhaoxia Dai

Frontiers in Oncology

doi 10.3389/fonc.2024.1339511

1,123 views

Original Research

Published on 18 Apr 2024

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors

in Thoracic Oncology

Balazs Halmos
Pragya Rai
Jae Min
Xiaohan Hu
Diana Chirovsky
Mark Shamoun
Bin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1285280

1,568 views
2 citations

Systematic Review

Published on 17 Apr 2024

Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis

in Thoracic Oncology

Yuxuan Cao
Xinbo Liu
Jiayi Liu
Ziyi Su
Wenxuan Liu
Lei Yang
Liwen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1357248

1,307 views

Case Report

Published on 16 Apr 2024

Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion

in Thoracic Oncology

Su-Su Dong
Wen Dong
Ya-Fen Tan
Qiang Xiao
Tian-Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1370901

868 views

Systematic Review

Published on 16 Apr 2024

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

in Thoracic Oncology

Wen Zhong
Xiaofei Zhao
Xiabiao Zhang
Yiwen Xu
Mengqian Liu
Xiaoyun Yang
Yi Jiang
Xiaozhu Shen

Frontiers in Oncology

doi 10.3389/fonc.2024.1358101

2,106 views

Case Report

Published on 15 Apr 2024

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report

in Thoracic Oncology

Eleonora Faccioli
Federica Grosso
Andrea Dell’Amore
Sara Delfanti
Giovanni Zambello
Luigi Cerbone
Gianluca Canu
Antonina De Angelis
Viola Sambataro
Federica Pezzuto

Frontiers in Oncology

doi 10.3389/fonc.2024.1378530

936 views

Original Research

Published on 12 Apr 2024

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma

in Thoracic Oncology

Ye Wang
Yingqiu Song
Runze Wang
Yu Wu
Mo Li
Ke Xu
Rong He
Zheng Wang
Qingqing Li
Feng-Ming (Spring) Kong

Frontiers in Oncology

doi 10.3389/fonc.2024.1265228

1,073 views

Navigation group

Articles

Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data

Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan

First-line immunotherapy efficacy in advanced squamous non-small cell lung cancer with PD-L1 expression ≥50%: a network meta-analysis of randomized controlled trials

ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report

Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression

Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review

TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

Editorial: Updates on combination therapy for lung cancer volume II

Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors

Diagnostic value of exosomal noncoding RNA in lung cancer: a meta-analysis

Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion

Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma